In the four HCT116-derived camptothecin-resistant colon cancer sublines, each with mutations in Top1 was demonstrated to decrease potency of camptothecin analogues [7], FL118 showed greater potency than SN-38 overall. Here, TOP1 is linked to malignant colon neoplasm.